Dashboard
Manage Tickers

JNJJOHNSON & JOHNSON

NYSE jnj.com


$ 163.17 $ -1.65 (-1 %)    

Thursday, 12-Sep-2024 11:13:08 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 471.61 $ 2.98 (0.64 %)
DIA $ 409.43 $ -0.03 (-0.01 %)
SPY $ 556.45 $ 1.46 (0.26 %)
TLT $ 100.01 $ -0.36 (-0.35 %)
GLD $ 235.75 $ 1.11 (0.47 %)
$ 164.82
$ 164.23
$ 163.21 x 100
$ 169.50 x 178
$ 164.23 - $ 165.05
$ 140.50 - $ 168.85
5,920,165
na
396.76B
$ 0.47
$ 10.44
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-25-2024 06-30-2024 10-Q
2 05-01-2024 03-31-2024 10-Q
3 02-16-2024 12-31-2023 10-K
4 10-27-2023 10-01-2023 10-Q
5 10-27-2023 10-01-2023 10-Q
6 07-31-2023 07-02-2023 10-Q
7 04-28-2023 04-02-2023 10-Q
8 02-16-2023 01-01-2023 10-K
9 10-27-2022 10-02-2022 10-Q
10 07-29-2022 07-03-2022 10-Q
11 04-29-2022 04-03-2022 10-Q
12 02-17-2022 01-02-2022 10-K
13 10-29-2021 10-03-2021 10-Q
14 07-29-2021 07-04-2021 10-Q
15 04-30-2021 04-04-2021 10-Q
16 02-22-2021 01-03-2021 10-K
17 10-23-2020 09-27-2020 10-Q
18 07-24-2020 06-28-2020 10-Q
19 04-29-2020 03-29-2020 10-Q
20 02-18-2020 12-29-2019 10-K
21 10-28-2019 09-29-2019 10-Q
22 07-29-2019 06-30-2019 10-Q
23 05-01-2019 03-31-2019 10-Q
24 02-20-2019 12-30-2018 10-K
25 10-31-2018 09-30-2018 10-Q
26 08-02-2018 07-01-2018 10-Q
27 05-01-2018 04-01-2018 10-Q
28 02-21-2018 12-31-2017 10-K
29 11-02-2017 10-01-2017 10-Q
30 08-03-2017 07-02-2017 10-Q
31 05-08-2017 04-02-2017 10-Q
32 02-27-2017 01-01-2017 10-K
33 11-04-2016 10-02-2016 10-Q
34 08-04-2016 07-03-2016 10-Q
35 05-10-2016 04-03-2016 10-Q
36 02-24-2016 01-03-2016 10-K
37 10-30-2015 09-27-2015 10-Q
38 07-31-2015 06-28-2015 10-Q
39 05-01-2015 03-29-2015 10-Q
40 02-24-2015 12-28-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

competitor-analysis-evaluating-johnson-amp-johnson-and-competitors-in-pharmaceuticals-industry
Competitor Analysis: Evaluating Johnson &a...
09/12/2024 15:00:49

johnson--johnson-seeks-first-eu-approval-of-nipocalimab-to-treat-broad-population-of-patients-living-with-antibody-positive-generalised-myasthenia-gravis
Johnson & Johnson Seeks First EU Approval ...
09/12/2024 14:12:54

-Reuters

how-to-earn-500-a-month-from-johnson--johnson-stock
How To Earn $500 A Month From Johnson & Jo...
09/12/2024 12:33:40

Johnson & Johnson offers an annual dividend yield of 3.01%. How can investors exploit its dividend yield to pocket a regula...

reported-earlier-fda-approves-johnson--johnsons-tremfya-for-adults-with-moderately-to-severely-active-ulcerative-colitis
Reported Earlier, FDA Approves Johnson & J...
09/12/2024 07:17:51

The first and only dual-acting interleukin-23 inhibitor approved in active ulcerative colitis, TREMFYA® showed highly statist...

metals-in-tampons-fda-initiates-new-safety-measures-and-testing
Metals in Tampons: FDA Initiates New Safet...
09/11/2024 18:37:40

The FDA is investigating concerns about metals in tampons after a 2024 study. The agency is conducting an internal study and re...

sony-music-universal-music-jv-hits-johnson--johnson-with-copyright-lawsuit-over-unlicensed-music-use-covering-80-videos
Sony Music-Universal Music JV Hits Johnson...
09/11/2024 18:32:22

Johnson & Johnson is facing a lawsuit from Associated Production Music for allegedly using unlicensed music in nearly 80 vi...

johnson--johnsons-mid-stage-lung-cancer-trial-reveals-fewer-infusion-related-reactions
Johnson & Johnson's Mid-Stage Lung Cancer ...
09/11/2024 13:08:23

Johnson & Johnson announced promising Phase 2 SKIPPirr study results for Rybrevant in reducing infusion-related reactions i...

johnson--johnson-says-dexamethasone-reduces-infusion-related-reactions-in-patients-with-egfr-mutated-non-small-cell-lung-cancer-treated-with-intravenous-rybrevant
Johnson & Johnson Says Dexamethasone Reduc...
09/10/2024 21:21:15

The study, which included 40 patients, showed that prophylaxis with 8-mg dexamethasone taken for two days prior to the first in...

Core News & Articles
FDA Says Aware Of Concerns About Tampon Sa...
09/10/2024 19:00:12

- Reuters

protagonist-therapeutics-two-investigational-candidates-target-over-10b-market-bullish-analyst-opines
Protagonist Therapeutics' Two Investigatio...
09/10/2024 17:17:00

Truist Securities has initiated coverage on Protagonist Therapeutics, praising its first-in-class lead asset with promising Pha...

kenvue-set-to-pop-like-a-tylenol-gelcap-golden-cross-looms-on-stock-chart
Kenvue Set To Pop Like A Tylenol Gelcap? G...
09/10/2024 12:48:40

Kenvue Inc., owner of major brands like Tylenol, is poised for a technical knockout with a Golden Cross pattern and legal win.

cantor-fitzgerald-reiterates-overweight-on-johnson--johnson-maintains-215-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 12:53:38

Cantor Fitzgerald analyst Louise Chen reiterates Johnson & Johnson (NYSE:JNJ) with a Overweight and maintains $215 price...

reported-sunday-johnson--johnson-unveils-long-term-data-from-mariposa-study-showing-rybrevant-plus-lazcluze-outperforming-osimertinib-in-lung-cancer-treatment
Reported Sunday, Johnson & Johnson Unveils...
09/09/2024 07:26:53

New longer-term data from the MARIPOSA study confirm superior outcomes of chemotherapy-free RYBREVANT® plus LAZCLUZE™ regimen...

dell-costar-paypal-and-a-major-health-care-stock-on-cnbcs-final-trades
Dell, CoStar, PayPal And A Major Health Ca...
09/06/2024 12:47:00

Bill Baruch of Blue Line Capital named Dell Technologies Inc. his "final trade" on CNBC's "Halftime Report."

wall-streets-most-accurate-analysts-weigh-in-on-3-health-care-stocks-with-over-3-dividend-yields
Wall Street's Most Accurate Analysts Weigh...
09/06/2024 12:21:22

johnson--johnson-raises-talc-settlement-offer-to-9b-moves-closer-to-settlement-victory
Johnson & Johnson Raises Talc Settlement O...
09/05/2024 18:30:04

Johnson & Johnson boosts talc settlement offer to $9 billion, gaining support from key lawyer Allen Smith for quicker claim...

Core News & Articles
CNBC Halftime Report Final Trades: PayPal,...
09/05/2024 17:02:43

psychedelic-drugs-market-set-to-grow-by-137b-by-2028-driven-by-mental-health-disorders-and-ai-integration
Psychedelic Drugs Market Set To Grow By $1...
09/05/2024 16:53:46

The global psychedelic drugs market is projected to grow by USD 1.37 billion by 2028, driven by mental health needs and AI adva...

johnson--johnson-wins-over-longtime-holdout-for-talc-settlement-tort-lawyer-allen-smith-now-backs-jjs-settlement-plan-after-the-company-raised-its-offer-to-roughly-9b-sources-say---wsj
"Johnson & Johnson Wins Over Longtime Hold...
09/04/2024 20:12:26

https://www.wsj.com/articles/johnson-johnson-wins-over-longtime-holdout-for-talc-settlement-0db573d7?page=1 Johnson & Johns...

court-orders-johnson--johnson-to-compensate-auris-health-shareholders-1b
Court Orders Johnson & Johnson To Compensa...
09/04/2024 18:12:58

Johnson & Johnson is ordered to pay $1 billion in damages to Auris Health shareholders for breaching a 2019 merger agreemen...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION